Wells Fargo’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Sell
109,952
-47,940
-30% -$429K ﹤0.01% 3687
2025
Q4
$1.34M Buy
157,892
+56,352
+55% +$402K ﹤0.01% 3744
2025
Q3
$530K Buy
101,540
+16,560
+19% +$63.1K ﹤0.01% 4267
2025
Q2
$294K Buy
84,980
+9,466
+13% +$28.2K ﹤0.01% 4511
2025
Q1
$198K Buy
75,514
+4,089
+6% +$16K ﹤0.01% 4709
2024
Q4
$294K Sell
71,425
-59,042
-45% -$321K ﹤0.01% 4544
2024
Q3
$924K Buy
130,467
+86,662
+198% +$647K ﹤0.01% 3593
2024
Q2
$286K Buy
43,805
+10,274
+31% +$70.2K ﹤0.01% 4270
2024
Q1
$278K Buy
33,531
+5,682
+20% +$55.4K ﹤0.01% 4262
2023
Q4
$307K Sell
27,849
-63,741
-70% -$538K ﹤0.01% 4203
2023
Q3
$770K Sell
91,590
-49,651
-35% -$534K ﹤0.01% 3503
2023
Q2
$1.77M Buy
141,241
+51,516
+57% +$641K ﹤0.01% 3016
2023
Q1
$1.48M Buy
89,725
+88,819
+9,803% +$1.59M ﹤0.01% 3115
2022
Q4
$13.5K Sell
906
-1,727
-66% -$33.1K ﹤0.01% 5424
2022
Q3
$59K Sell
2,633
-748
-22% -$16.4K ﹤0.01% 4876
2022
Q2
$56K Sell
3,381
-20,713
-86% -$444K ﹤0.01% 4970
2022
Q1
$721K Sell
24,094
-22,726
-49% -$551K ﹤0.01% 4141
2021
Q4
$1.44M Sell
46,820
-3,646
-7% -$115K ﹤0.01% 3811
2021
Q3
$1.59M Buy
50,466
+19,867
+65% +$669K ﹤0.01% 3865
2021
Q2
$1.12M Buy
30,599
+20,779
+212% +$685K ﹤0.01% 4134
2021
Q1
$340K Sell
9,820
-13,386
-58% -$581K ﹤0.01% 4898
2020
Q4
$964K Sell
23,206
-9,810
-30% -$443K ﹤0.01% 4059
2020
Q3
$1.41M Buy
+33,016
New +$1.26M ﹤0.01% 3604

Other funds holding RLAY